Q3FY17 Results : Cipla

Bhagyashree Vivarekar / 08 Feb 2017

Q3FY17 Results : Cipla

The company reported PAT of Rs 385.8 crore, which represents a sequential QoQ increase of 3.79 per cent and a YoY increase of 41.79 per cent.

Cipla Ltd. reported its consolidated results for the quarter ended December 31, 2016 today. 

The company reported sales of Rs 3647 crore for Q3FY17, which represents a 2.77 per cent sequential decline and 15.78 per cent YoY increase.

Its operating profit (EBIT) for the quarter was Rs 420 crore and its EBIT margin was 11.52 per cent.

The company reported PAT of Rs 385.8 crore, which represents a sequential QoQ increase of 3.79 per cent and a YoY increase of 41.79 per cent.

The company's stock opened at Rs 599 on the BSE and rose 0.95 per cent. It closed for the day at Rs 676.8.

Cipla Ltd is an Indian pharmaceutical company engaged in manufacture of prescription drugs, OTC products and veterinary products. Cipla also exports of raw materials and intermediates and offers technology for products and processes.

If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.